Abstract:Abstract Lung cancer is the most common cancer, which also leading cause of global cancer mortality. Metastasis is a complex multi-step process that represents the most deadly aspect of cancer. One key step in metastasis is the entry of circulating tumor cells (CTCs) into secondary or distant organ sites to become disseminated tumor cells for subsequent metastasis. Exosomes, a subset of extracellular vesicles (EVs), function as a mode of intercellular communication and molecular transfer. Tumor cells are avid producers of exosomes, and tumour-derived exosomes uptaken by organ-specific cells prepare the pre-metastatic niche. The aim of this pilot study is to investigate the relationship between the count of circulating tumor cells in peripheral blood and the clinical stage of lung cancer, and the difference between normal (healthy) person exosomes and cancer patients exosomes in the rate of exosomes release and the content (most notably proteins). A total of 140 patients participated in the project and twelve blood samples from healthy volunteers were also collected in the Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. After obtaining the informed consent, blood samples (5 ml) were stored in the ACD anticoagulant tube. CTCs was counted by immunomagnetic beads negative enrichment technique combined with immunofluorescence staining of chromosome in situ hybridization. The correlation between the count of CTCs and the clinical stage was analyzed. Exosomes were isolated by Density Gradient (DG) centrifugation. Exosomes concentration and size was analyzed by Nanoparticle Tracking Analysis (NTA), and protein was analyzed by HPLC-CHIP-MS/MS. In 114 patients, the positive rate of CTCs was 93.86% (in 3.2mL blood CTCs≥1, 107/114). The count of CTCs was negatively correlated with clinical stage (rs=-0.279, p=0.003), which suggest that CTCs is highly expressed in early lung cancer patients. Exosomes test results showed that there was a significant difference between lung cancer patients and healthy person. The size of exosome in healthy person was significantly smaller and the concentration was significantly higher when compared with lung cancer patients (p<0.05). In addition, the mass spectrometry results showed that the control group had 135 proteins in the exosomes, while the patient group contained 167 proteins, which 89 proteins were shared with each other. These results suggest that CTCs plays an important role in the pathogenesis of lung cancer and should be a target for early postoperative metastasis. The analysis of exosomes in NSCLC could represent a noninvasive test for assess disease progression. Citation Format: Zujun Que, Yi Jiang, Fangfang Qian, Zhi Qiao, Hua Xiao, Lingshuang Liu, Hegen Li, Jianhui Tian. Correlation of exosomes and CTCs in non-small cell lung cancer patients with disease stage [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 1577.

Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.

Proteomic and Phosphoproteomic Maps of Lung Squamous Cell Carcinoma from Chinese Patients.

Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.

Proteomic Analysis of Plasma Exosomes in Patients with Non-Small Cell Lung Cancer

Identification of Exosome Protein Panels As Predictive Biomarkers for Non-Small Cell Lung Cancer

Expression of Mucin Family Proteins in Non-Small-Cell Lung Cancer and Its Role in Evaluation of Prognosis

Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer

Glypican-1 in Serum-Derived Exosomes As a Potential Biomarker in Liquid Biopsy of Non-Small Cell Lung Cancer

PLA2G10 Incorporated in Exosomes Could Be Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer

Plasma exosomes contain protein biomarkers valuable for the diagnosis of lung cancer

Analysis of Differentially Expressed Proteome in Urinary Exosome from Non-small Cell Lung Cancer Patients

Circulating Exosomes Contain Protein Biomarkers of Metastatic Non-Small-cell Lung Cancer.

The Mtdna Fragments Within Exosomes Might Be Novel Diagnostic Biomarkers of Non-Small Cell Lung Cancer.

Serum Exosomal Proteomics Analysis of Lung Adenocarcinoma to Discover New Tumor Markers

Comparative proteomic profiling of plasma exosomes in patients with lung cancer with brain metastasis and liver metastasis.

Abstract 1577: Correlation of Exosomes and CTCs in Non-Small Cell Lung Cancer Patients with Disease Stage

Comparative Proteomic Profiling of Plasma Exosomes in Lung Cancer Cases of Liver and Brain Metastasis.

Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer

Clinical Significance of MUC1 Mrna Expression in Peripheral Blood and Bone Marrow in Patients with Lung Cancer

Tumor-derived exosomal miR-155-5p and miR-658 in serum as diagnostic biomarkers for early-stage non-small cell lung cancer

Characterization of Exosomes in Plasma of Patients with Breast, Ovarian, Prostate, Hepatic, Gastric, Colon, and Pancreatic Cancers